loader image
Saturday, February 22, 2025
43.7 F
McAllen
We Welcome your Press Release
- Advertisement -

Edinburg Begins Efforts to Control Mosquitoes

Translate to Spanish or other 102 languages!

Mega Doctor News 

- Advertisement -

Edinburg Texas­-The City of Edinburg has begun the process to diminish the reproduction of mosquitoes. With the recent break in rainfall this weekend, crews began larviciding visible standing water through out the City.

Larviciding is an ecologically safe preventive method used to interrupt the development of larvae or pupa into adult mosquitoes. The process targets mosquitoes in their habitats where they reproduce, before they are biting adults.

This evening crews will also begin adulticiding (spraying) the northwest side and the southeast side of the City and will alternate morning and evening for two cycles. Crews will then re-evaluate the progress to determine if the process needs to continue. Crews will also continue to larvicide standing water not already treated.

- Advertisement -

As a reminder, residents are asked to assess their properties by checking containers around their homes that create a habitat for mosquitoes to lay their eggs. These containers should either be dumped out every three days, or covered to prevent the collection of water.

To be most effective, spraying is usually done at dusk and dawn when mosquitoes are most active.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×